Business Description
Northwest Biotherapeutics is a Maryland-based company working to fight cancer by harnessing the body's own immune system. Their core approach involves training specialized immune cells, called dendritic cells, to recognize and attack tumors in individual patients. The company's most advanced treatment targets an aggressive form of brain cancer and has already completed large-scale clinical testing, while a second treatment aimed at hard-to-operate-on tumors has also shown early promise.